Symbiotec Pharmalab Ltd IPO was priced at ₹938–₹988 per share with an issue size of ₹1,757 crore. The IPO opened on Aug 24, 2026 and closed on Aug 27, 2026, with a lot size of 15 shares and a minimum investment of ₹14,820.
Subscription data isn't available yet — it appears once bidding opens.
| Price Band | ₹938.00 - ₹988.00 per share |
| Lot Size | 15 shares |
| Min Investment | ₹14,820 |
| Total Issue Size | ₹1757.00 crore |
| Shares Offered | 1,77,86,442 |
| Issue Structure | Fresh Issue + Offer for Sale |
| Issue Type | Bookbuilding IPO |
| Lead Manager(s) | JM Financial Ltd., Avendus Capital Pvt.Ltd., Motilal Oswal Investment Advisors Ltd., Nomura Financial Advisory & Securities (India) Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. |
| Listing At | BSE, NSE |
Issue price ₹988 · lot size 15 shares · estimated listing price ₹1,193 (GMP +₹205)
| Category | Lots | Shares | Investment | Value at listing | Profit |
|---|---|---|---|---|---|
| Retail (Min) | 1 | 15 | ₹14,820 | ₹17,895 | +₹3,075 |
| Retail (Max) | 13 | 195 | ₹1,92,660 | ₹2,32,635 | +₹39,975 |
| S-HNI (Min) | 14 | 210 | ₹2,07,480 | ₹2,50,530 | +₹43,050 |
| S-HNI (UPI limit) | 33 | 495 | ₹4,89,060 | ₹5,90,535 | +₹1,01,475 |
| S-HNI (Max) | 67 | 1,005 | ₹9,92,940 | ₹11,98,965 | +₹2,06,025 |
| B-HNI (Min) | 68 | 1,020 | ₹10,07,760 | ₹12,16,860 | +₹2,09,100 |
| Metric | Latest Reported |
|---|---|
| Total Income | ₹872.26 Cr |
| Profit After Tax | ₹109.90 Cr |
| Net Worth | ₹1158.64 Cr |
Promoters: Anil Satwani, Kashish Satwani, Sushil Satwani
| Promoter Holding (Pre-Issue) | 61681496% |
| Promoter Holding (Post-Issue) | 63202757% |
Symbiotec Pharmalab Ltd. is a pharmaceutical and biotechnology company engaged in the development and manufacturing of active pharmaceutical ingredients (APIs), nutritional ingredients, and specialty products.
Evolved from a lab-scale steroidal hormone API manufacturer in 1995 into an industrial-scale, backward-integrated manufacturing platform.
| Founded | 2002 |
| Headquarters | Indore, Madhya Pradesh |
| Industry | Pharmaceuticals |
| Website | https://www.symbiotec.com/ |
| Registrar | MUFG Intime India Pvt.Ltd. |
| Phone | 022-49186000 |
| [email protected] |
11 answers about Symbiotec Pharmalab Ltd IPO — dates, pricing, allotment and listing.
Symbiotec Pharmalab Ltd IPO is a bookbuilding ipo of ₹1,757 crore. The issue was priced at ₹938–₹988 per share, with a lot size of 15 shares. Bidding ran from Mon, 24 Aug 2026 to Thu, 27 Aug 2026, with shares listed on BSE and NSE.
The price band was ₹938–₹988 per share.
One lot was 15 shares. Bids had to be placed in multiples of 15.
A retail investor needed at least ₹14,820 – one lot of 15 shares at ₹988, the upper end of the price band.
Symbiotec Pharmalab Ltd IPO opened on Mon, 24 Aug 2026 and closed on Thu, 27 Aug 2026.
Allotment was finalised on Fri, 28 Aug 2026.
Symbiotec Pharmalab Ltd shares were listed on Tue, 01 Sep 2026 on BSE and NSE.
The company intended to use the net proceeds towards prepayment and/or repayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the company and general corporate purposes.
JM Financial Ltd., Avendus Capital Pvt.Ltd., Motilal Oswal Investment Advisors Ltd. and Nomura Financial Advisory & Securities (India) Pvt.Ltd. are the book running lead managers. MUFG Intime India Pvt.Ltd is the registrar to the issue.
Category-wise demand from retail, NII and QIB bidders is on the Symbiotec Pharmalab Ltd IPO subscription page, and on the BSE and NSE websites.
From Fri, 28 Aug 2026, check the Symbiotec Pharmalab Ltd IPO allotment status using your PAN, application number or DP ID – also available on the registrar's website.